The Nagoya Protocol implements the objectives of the Convention on Biological Diversity (CBD) regarding ”access and benefit sharing”. It regulates:
- Access to genetic resources, e.g., it facilities access for companies and research institutions to genetic material from plants, animals and other organisms in provider countries.
- The sharing of the benefits which result from the use of genetic resources (”access and benefit sharing”) by allowing the countries that provide these materials to obtain benefits in a balanced and fair way.
21.09.2018 | Law and policy
Information event on the revised Patents Act for experts and practitioners
Info event on using strategic patent analyses on 11.4.2018 in Zurich
14.02.2018 | Event
Stakeholder Discussions on: Innovation, availability and affordability of medical products. Can we achieve it all?
Séminaire IPI / LES: «développements récents en droit des marques», jeudi le 9 novembre 2017 au Novotel Genève
Patents and pharmaceuticals - Public event at the IPI in collaboration with the European Patent Office